Myanmar Healthcare Monthly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Healthcare Monthly.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 3, 2025

September 3, 2025

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

GlobeNewswire

September 3, 2025

C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society (IMS) Annual Meeting

GlobeNewswire

September 3, 2025

MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire

September 3, 2025

ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310

GlobeNewswire

September 3, 2025

XORTX Initiates IND Preparation for XORLO™ in Gout Program

GlobeNewswire

September 3, 2025

Aclarion Appoints Greg Gould as Chief Financial Officer

GlobeNewswire

September 3, 2025

Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research

GlobeNewswire

September 3, 2025

Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor

GlobeNewswire

September 3, 2025

Renovamen Advisors® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models

GlobeNewswire

September 3, 2025

Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment

GlobeNewswire

September 3, 2025

Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate

GlobeNewswire

September 3, 2025

Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité de Phase 2 pour le candidat vaccin contre la maladie de Lyme

GlobeNewswire

September 3, 2025

NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer

GlobeNewswire

September 3, 2025

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

GlobeNewswire